Advances in Pharma Business Management and Research

Preface
Contents
About the Editors
Introduction: Trends and Developments in the Pharmaceutical and Life Sciences Industry
Relevance of Instruments for Measurements of Quality of Life in the AMNOG Context: An Analysis of the Endpoint Health-Related ...
	1 Relevance of Instruments for Measurements of Quality of Life in the AMNOG Context
		1.1 An Analysis of the Endpoint Health-Related Quality of Life from Different Perspectives
	2 Methods
	3 Results and Conclusions
	4 Outlook
	References
Quality Management System for RandD Project and Portfolio Management in Pharmaceutical Company
	1 Introduction
	2 Theoretical Background
		2.1 Theories
		2.2 Pharmaceutical Project Management Quality System Model
		2.3 Hypotheses
	3 Empirical Analysis
		3.1 Methodology
			3.1.1 Characterization of PPMQS Enabling and Result Systems
		3.2 Testing of Hypotheses
	4 Empirical Findings
		4.1 Characterization of Enabling and Result Systems
		4.2 Testing of Hypotheses
	5 Discussion
	References
Brexit and Its Impact on Pharmaceutical Law: Implications for Global Pharma Companies
	1 Brexit Scenarios
	2 Impact on the Drug Regulatory Framework
	3 Recommended Actions for Companies
	4 Conclusions and Outlook
	References
Implementation of Measurable and Sustainable Actions to Improve Employee´s Engagement and Business Performance: Global Medical...
	1 Background
	2 Statement of Expectations
		2.1 With Onboarding the Bond of Employees to the Company will be Increased
		2.2 Regular Feedback Meetings with Superiors will Engage Employees
		2.3 Personal Development Plans will Lead to Better Performance
	3 Managerial Implications
		3.1 Implications on Fresenius Kabi
	4 Direction for Future Research
	5 Conclusion
	References
Leadership Models and Work Behavior: An Empirical Analysis of Consequences of Authentic and Transformational Leadership
	1 The Importance of Leadership for Corporate Success
	2 The Concept of Leadership
	3 Constructs and Generation of Hypotheses
	4 Empirical Assessment of the Models
	5 Summary, Implications and Outlook
	References
Alliance Management at Merck: Establishing an Operational 100-Day Plan for Alliance Launches and Management
	1 Introduction
	2 The Importance of Alliances for the Pharmaceutical Industry
		2.1 The Problem ``Productivity Paradox´´
		2.2 Cooperation as a Potential Solution
	3 The Nature of Alliances
		3.1 Definitions and Types of Alliances
		3.2 The Lifecycle of Alliances
		3.3 The Role of the Alliance Management
	4 Merck KGaA and Its Alliances
		4.1 History of Merck KGaA
		4.2 Significant Biopharma Alliances of Merck
		4.3 Alliance Management at Merck
	5 The Operational 100-Day Plan
	6 The Online Survey on the 100-Day Plan
		6.1 General Statistics
		6.2 Alliance Launch Phase
		6.3 Governance of Alliances
		6.4 Evaluation of Alliances
		6.5 Feedback on the 100-Day Plan
	7 Conclusion and Outlook
	Appendix 1: Operational 100-Day Plan for Alliance Launch
	References
Correction to: Introduction: Trends and Developments in the Pharmaceutical and Life Sciences Industry
	Correction to: Chapter 1 in: L. Schweizer et al. (eds.), Advances in Pharma Business Management and Research, https://doi.org/...